Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Switzerland

 

Swiss Prime Site’s Tertianum for sale

Listed real-estate investor Swiss Prime Site (SPS) has put its assisted living opco Tertianum for sale. We speak to an advisor following this space and hear from Credit Suisse, appointed to advise on the deal, about the Swiss residential care market.

Dentistry: At a tipping point for PE consolidators

Retail healthcare investors who have seen the European veterinary space undergo an eight-year period of rapid practice consolidation by private-equity backed groups are beginning to look at dentistry. Will yesterday's investors in vets tomorrow invest in dentists? HBI chats to Mansfield Advisors to find out more about how dentistry could be at a price tipping point that will favour big consolidators.

€10bn battle of the labs as Unilabs and Synlab mull 2020 sales

Europe's largest lab groups could both sell in 2020, with Apax appointing Rothschild to explore a sale of Unilabs while Synlab's majority owner Cinven is also weighing up an exit. The sale values including debt could potentially reach €10bn combined.

FREE BLOG New HBI pipeline tool reveals long-held investments 

Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.

Hirslanden-Sana procurement deal “going to plan” while Head of Procurement leaves

Mediclinic-owned Swiss hospital group Hirslanden and German counterpart Sana Kliniken previously-announced cooperation on procurement has split opinion, with a source close to the companies saying it is "going to plan and savings have been generated" while a consultant tells it has been less successful. What is incontrovertible is that Hirslanden has parted ways with its head of procurement & supply chain after just a year in the job.

Exclusive: Change at the top at Unilabs

Jos Lamers, 55, the man widely seen as the architect of modern-day Unilabs is moving away from a full-time role at the Pan-European lab and imaging platform, HBI can exclusively reveal. So what lies behind the move and who succeeds him as CEO?

Interview: Dr Volker Wendel, Sanoptis CEO

How do you build a €100m European ophthalmology group without attracting headlines? HBI speaks to the CEO of the new kid on the block Sanoptis, which has a significant presence now in German and Switzerland, to find out why it has been deliberately operating under the radar – and how it’s managed to quietly build a €100m business in the space of a year.

FREE BLOG Europe’s €18bn fragmented private imaging sector ripe for change

What has emerged during our research for HBI Intelligence's imaging report, now live on our site, is how fragmented the sector is compared to other services. It will be utterly revolutionised by regulatory and tariff changes, AI/teleradiology and changing service-supplier dynamics; it's just no one is sure exactly how.

Interview: Julian Andriesz, CEO, Verita Healthcare

The massive latent demand to live longer is being tapped by a new generation of health care providers. British entrepreneur Julian Andriesz, 53, made a first fortune building business in SE Asia and got into prevention after watching his mother die of ovarian cancer, diagnosed late. He says his intention is to help his clients, whether they are healthy, have cancer or auto-immune diseases, to live longer, better lives. Verita has a chain of 10 clinics, believes its digital health disease prevention and management platform is about to become the largest in the world and owns IP, and research and manufacturing in Europe, Asia and Australia.

Find Us